May 2 |
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
|
May 2 |
AxoGen Non-GAAP EPS of -$0.06 beats by $0.01, revenue of $41.4M misses by $0.65M
|
May 2 |
Axogen, Inc Reports First Quarter 2024 Financial Results
|
May 1 |
AxoGen Q1 2024 Earnings Preview
|
May 1 |
AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
|
Apr 29 |
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
|
Apr 16 |
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
|
Apr 4 |
Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long
|